Contrast sensitivity in multiple sclerosis measured by Cambridge Low Contrast Gratings: a useful clinical test?
Authors:
- D GlynnDGD Glynn
- M HutchinsonMHM Hutchinson
Open Access
- 1 June 1989
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 52 (6) , 786-787
Abstract
The Cambridge Low Contrast Gratings (CLCG) were used to assess contrast sensitivity (CS) in 39 patients with clinically definite multiple sclerosis and 60 control subjects. CS was determined in both horizontal and vertical orientations and compared with visual evoked responses (VERs) in the same populations. Only 33% of patients had abnormal CS whereas 82% had abnormal VERs. There was no correlation between the degree of abnormalities in CS and VERs. There was no significant difference between CS determined in the vertical and horizontal orientation; however, examination in the vertical orientation increased the number of abnormalities detected by 2 (5%). We conclude that although CS, using the CLCG, is abnormal in a proportion of multiple sclerosis patients its detection is not clinically useful and is insensitive as a measure of subclinical optic neuropathy in multiple sclerosis.Keywords
This publication has 5 references indexed in Scilit:
- The rapid assessment of visual dysfunction in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Visual evoked responses and immunoglobulin abnormalities in the diagnosis of multiple sclerosisActa Neurologica Scandinavica, 1983
- Orientation-Specific Visual Evoked Potential Deficits in Multiple SclerosisCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1982
- VISUAL ACUITY AND CONTRAST SENSITIVITY IN MULTIPLE SCLEROSIS—HIDDEN VISUAL LOSSBrain, 1977
- DIAGNOSIS AND CLASSIFICATION OF MULTIPLE SCLEROSISBritish Medical Bulletin, 1977